Translation of Molecular Pathways into Clinical Trials of Neuroendocrine Tumors
Neuroendocrinology, 04/16/2012
Pavel M – The review provides a broad overview of established and potential molecular targets in neuroendocrine tumors (NET), summarizes data from phase II and III clinical trials with targeted drugs and outlines future therapeutic directions.



